Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Lateral Flow Assay for Diagnosis of Endometriosis

FY 2018-19

Summary
diagnostic test and therapeutic for endometriosis. Endometriosis is an immunologic condition that affects one in*ten women causing them to suffer daily debilitating pain, abnormal bleeding and infertility. The impact on quality*of life and productivity due to pelvic pain and infertility is extremely substantial. Unfortunately, this disease*remains misdiagnosed, misunderstood and ineffectively treated. SYNG Pharmaceuticals has engineered*proprietary antibodies for a newly discovered potential biomarker for endometriosis. It is looking for the*experienced partner to help develop a biosensor for a rapid test to diagnose the disease with adequate sensitivity*and specificity.*Professor Cynthia Goh from the University of Toronto, an expert in biomaterials, nanotechnology, and surface*chemistry has invented a new type of biosensors based on light diffraction. This technology was commercialized*by spinning off Axela Biosensors Inc. Her fundamental knowledge of biosensors enables to create a foundation for*the development of any immunoassay based diagnostic devices. The goal of this project is to develop a point of*care, easy to use prototype based on a lateral flow technique to perform instantaneous detection of*endometriosis. The success of this project will accelerate the market entry for SYNG Pharmaceuticals new*diagnostic device which, in turn, will assist the process of development and commercialization of endometriosis*therapeutic, a target that SYNG Pharmaceuticals aims to overcome in nearest future.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
531260-2018
Name nom
Goh, MCynthia
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Lateral Flow Assay for Diagnosis of Endometriosis
Keyword
NSERC
Application summary
diagnostic test and therapeutic for endometriosis. Endometriosis is an immunologic condition that affects one in*ten women causing them to suffer daily debilitating pain, abnormal bleeding and infertility. The impact on quality*of life and productivity due to pelvic pain and infertility is extremely substantial. Unfortunately, this disease*remains misdiagnosed, misunderstood and ineffectively treated. SYNG Pharmaceuticals has engineered*proprietary antibodies for a newly discovered potential biomarker for endometriosis. It is looking for the*experienced partner to help develop a biosensor for a rapid test to diagnose the disease with adequate sensitivity*and specificity.*Professor Cynthia Goh from the University of Toronto, an expert in biomaterials, nanotechnology, and surface*chemistry has invented a new type of biosensors based on light diffraction. This technology was commercialized*by spinning off Axela Biosensors Inc. Her fundamental knowledge of biosensors enables to create a foundation for*the development of any immunoassay based diagnostic devices. The goal of this project is to develop a point of*care, easy to use prototype based on a lateral flow technique to perform instantaneous detection of*endometriosis. The success of this project will accelerate the market entry for SYNG Pharmaceuticals new*diagnostic device which, in turn, will assist the process of development and commercialization of endometriosis*therapeutic, a target that SYNG Pharmaceuticals aims to overcome in nearest future.